ARCHIVES

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

This article is from The Cancer Letter archive.

Vol. 27 No. 3 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

NCI-Approved Protocols Listed

March 28, 2003

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

NCCF, Ad Council plan public service ads on childhood cancer.

November 7, 2003